Dr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology at Stanford University Medical School, and a Co-founder/Managing Partner at Triventures. Peter is an Interventional Cardiologist and holds a PhD in Engineering. He is Professor Emeritus in the Departments of Medicine and Engineering at Stanford. He has also led or participated in over 150 clinical trials, published over 450 manuscripts/chapters, and lectures worldwide. Peter has been principle/founder of 18 healthcare companies in Silicon Valley, has transitioned 13 of these start-ups to medium/large-cap life science companies and remains on several of their advisory boards. He has been a consultant for the FDA for the past 15 years focused. Prior to cofounding Triventures, Peter was a co-founding partner of LVP capital in San Francisco, deriving his experience in venture capital from three funds focused on medical device and biotechnology start-ups. Peter heads the US Triventures office.
Current role